UroGen Pharma Q3 EPS $(1.06) Up From $(1.28) YoY

UroGen Pharma (NASDAQ:URGN) reported quarterly losses of $(1.06) per share. This is a 17.19 percent increase over losses of $(1.28) per share from the same period last year.

Benzinga · 11/12/2019 13:30

UroGen Pharma (NASDAQ:URGN) reported quarterly losses of $(1.06) per share. This is a 17.19 percent increase over losses of $(1.28) per share from the same period last year.